Fristrup N - Search Results

1

Mutational context and diverse clonal development in early and late bladder cancer.

Nordentoft I, Lamy P, Birkenkamp-Demtröder K, Shumansky K, Vang S, Hornshøj H, Juul M, Villesen P, Hedegaard J, Roth A, Thorsen K, Høyer S, Borre M, Reinert T, Fristrup N, Dyrskjøt L, Shah S, Pedersen JS, Ørntoft TF. Nordentoft I, et al. Among authors: fristrup n. Cell Rep. 2014 Jun 12;7(5):1649-1663. doi: 10.1016/j.celrep.2014.04.038. Epub 2014 May 15. Cell Rep. 2014. PMID: 24835989 Free article.

2

Lifestyle and Clinical Factors in a Nationwide Stage III and IV Renal Cell Carcinoma Study.

Azawi N, Ebbestad FE, Nadler N, Mosholt KSS, Axelsen SS, Geertsen L, Christensen J, Jensen NV, Fristrup N, Lund L, Donskov F, Dalton SO. Azawi N, et al. Among authors: fristrup n. Cancers (Basel). 2023 Sep 9;15(18):4488. doi: 10.3390/cancers15184488. Cancers (Basel). 2023. PMID: 37760459 Free PMC article.

3

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF. Dyrskjøt L, et al. Among authors: fristrup n. Cancer Res. 2009 Jun 1;69(11):4851-60. doi: 10.1158/0008-5472.CAN-08-4043. Cancer Res. 2009. PMID: 19487295

4

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.

Egerod FL, Bartels A, Fristrup N, Borre M, Ørntoft TF, Oleksiewicz MB, Brünner N, Dyrskjøt L. Egerod FL, et al. Among authors: fristrup n. BMC Cancer. 2009 Oct 30;9:385. doi: 10.1186/1471-2407-9-385. BMC Cancer. 2009. PMID: 19878561 Free PMC article.

5

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.

Ostenfeld MS, Bramsen JB, Lamy P, Villadsen SB, Fristrup N, Sørensen KD, Ulhøi B, Borre M, Kjems J, Dyrskjøt L, Orntoft TF. Ostenfeld MS, et al. Among authors: fristrup n. Oncogene. 2010 Feb 18;29(7):1073-84. doi: 10.1038/onc.2009.395. Epub 2009 Nov 16. Oncogene. 2010. PMID: 19915607

6

High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy.

Jensen JB, Munksgaard PP, Sørensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhøi BP, Jensen KM, Ørntoft TF, Dyrskjøt L. Jensen JB, et al. Among authors: fristrup n. Eur Urol. 2011 May;59(5):841-8. doi: 10.1016/j.eururo.2011.01.048. Epub 2011 Feb 16. Eur Urol. 2011. PMID: 21330047

7

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.

Munksgaard PP, Mansilla F, Brems Eskildsen AS, Fristrup N, Birkenkamp-Demtröder K, Ulhøi BP, Borre M, Agerbæk M, Hermann GG, Orntoft TF, Dyrskjøt L. Munksgaard PP, et al. Among authors: fristrup n. Br J Cancer. 2011 Oct 25;105(9):1379-87. doi: 10.1038/bjc.2011.404. Epub 2011 Oct 6. Br J Cancer. 2011. PMID: 21979422 Free PMC article.

8

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.

Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, Gao S, Hansen TB, Jensen TI, Borre M, Ørntoft TF, Dyrskjøt L, Kjems J. Villadsen SB, et al. Among authors: fristrup n. Br J Cancer. 2012 Jan 17;106(2):366-74. doi: 10.1038/bjc.2011.520. Epub 2011 Nov 22. Br J Cancer. 2012. PMID: 22108519 Free PMC article.

9

Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.

Fristrup N, Ulhøi BP, Birkenkamp-Demtröder K, Mansilla F, Sanchez-Carbayo M, Segersten U, Malmström PU, Hartmann A, Palou J, Alvarez-Múgica M, Zieger K, Borre M, Ørntoft TF, Dyrskjøt L. Fristrup N, et al. Am J Pathol. 2012 May;180(5):1824-34. doi: 10.1016/j.ajpath.2012.01.023. Epub 2012 Mar 24. Am J Pathol. 2012. PMID: 22449953

10

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.

Schepeler T, Lamy P, Hvidberg V, Laurberg JR, Fristrup N, Reinert T, Bartkova J, Tropia L, Bartek J, Halazonetis TD, Pan CC, Borre M, Dyrskjøt L, Orntoft TF. Schepeler T, et al. Among authors: fristrup n. Oncogene. 2013 Aug 1;32(31):3577-86. doi: 10.1038/onc.2012.381. Epub 2012 Aug 27. Oncogene. 2013. PMID: 22926521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page